Cargando…
The hurdle with remaining risk for hepatocellular carcinoma in cirrhotic patients after a hepatitis C cure
After introduction of new direct acting antivirals (DAAs) against hepatitis C, the cure rate has increased substantially especially in patients with liver cirrhosis. Decreased but remaining risk for hepatocellular carcinoma (HCC) has been shown in patients with liver cirrhosis after cure, in previou...
Autor principal: | Aleman, Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918700/ https://www.ncbi.nlm.nih.gov/pubmed/30288315 http://dx.doi.org/10.1186/s41124-016-0019-3 |
Ejemplares similares
-
Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patients
por: Owusu Sekyere, Solomon, et al.
Publicado: (2021) -
Risk of hepatocellular carcinoma after hepatitis C virus cure
por: Luna-Cuadros, Maria Alejandra, et al.
Publicado: (2022) -
Long-term follow-up after cure from chronic hepatitis C virus infection shows occult hepatitis and a risk of hepatocellular carcinoma in noncirrhotic patients
por: Lybeck, Charlotte, et al.
Publicado: (2019) -
Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients
por: Cucchetti, Alessandro, et al.
Publicado: (2017) -
New hurdles for translational research
por: Dowsett, Mitch
Publicado: (2000)